Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  genetically engineered HSV-1 expressing IL-12
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
IL-12-Expressing HSV-1 in Treating Patients with Recurrent or Progressive Glioblastoma, Anaplastic Astrocytoma, or Gliosarcoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 19 and over
Trial IDs: UAB1317, NCI-2016-01806, NCT02062827
Start Over